New York Stock Exchange-listed China Cord Blood Corporation, in which KKR & Co. L.P. has made an investment, has received a take-private offer from its largest shareholder, Golden Meditech Holdings Limited, according to a company announcement. Hong Kong-listed Chinese healthcare firm Golden Meditech, which owns approximately 46.3% of China Cord Blood as of March 31, […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network